BlackRock Inc. - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 27 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q4 2019$4,000
-60.0%
19,9550.0%0.00%
Q3 2019$10,000
-28.6%
19,9550.0%0.00%
Q2 2019$14,000
-54.8%
19,9550.0%0.00%
Q1 2019$31,000
+3.3%
19,9550.0%0.00%
Q4 2018$30,000
-25.0%
19,9550.0%0.00%
Q3 2018$40,000
+17.6%
19,955
+0.0%
0.00%
Q2 2018$34,00019,9530.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q4 2019
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 1,125,000$253,0000.23%
IMS Capital Management 23,472$5,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 181$00.00%
UBS Group AG 44,664$10,0000.00%
IFP Advisors, Inc 0$00.00%
BNP PARIBAS FINANCIAL MARKETS 2$00.00%
Advisor Group, Inc. 785$00.00%
Jacobi Capital Management LLC 20$00.00%
BANK OF AMERICA CORP /DE/ 65$00.00%
FLAGSHIP HARBOR ADVISORS, LLC 3$00.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders